AWS Life Sciences Symposium 2025 | HCLTech
Pioneering patient-centric GenAI-led disruption at the AWS Life Sciences Symposium 2025
Section Title
Overview

Leading the way in driving innovation and transforming patient care with GenAI

GenAI and Agentic AI are poised to transform the life sciences and healthcare industries, with early pilots showing tremendous promise.

HCLTech and AWS are leading the way in AI-led life sciences innovation with a shared commitment to leveraging GenAI and Agentic AI to drive innovation and improve human health. Our partnership focuses on accelerating drug discovery, advancing personalized medicines, innovating devices/drug administration and optimizing patient care by leveraging GenAI’s ability to analyze vast patient datasets and automating routine processes. These advancements expedite therapeutic delivery and make it more accessible and affordable for everyone. 

Join us at the AWS Life Sciences Symposium 2025 to learn how this partnership between HCLTech and AWS is transforming the patient experience.

Section CTA

Focus areas

Research and development

Research and development

GenAI is reinvigorating product pipelines by accelerating the process of identifying compounds for possible new drugs and diagnostics, speeding up their development and approval and optimizing market access. 

AI and GenAI are also transforming drug repositioning strategies for products nearing loss of exclusivity, enabling regulatory compliance and addressing unmet medical needs.

Operational excellence

Operational excellence

Predictive and prescriptive AI-led analytics, coupled with digital twin methodologies and GenAI-based virtual assistants will help optimize drug and device manufacturing and supply chain management strategies.

Commercial excellence

Commercial excellence

GenAI will transform commercial operations from customer engagement strategies to product launch and lifecycle engagement. Potential transformations in medical and legal review processes and strategic insights generation will have a strong near-term impact on commercial operations.

Medical affairs

Medical affairs

Enabled by GenAI, integrated clinical evidence-generation strategies will transform medical affairs content generation, regulatory approvals, and patient and healthcare professionals' outreach while integrating real-world data/real-world evidence with asset plans and portfolio strategies.

Section CTA

Our solutions

Section Description

As strategic partners, HCLTech and AWS provide innovative healthcare and life sciences solutions. From accelerating drug discovery to enhancing personalized medicine, designing groundbreaking medical devices and digital health solutions, optimizing patient care and providing after-market support, we are committed to improving outcomes through advanced AI-driven technologies and operational excellence. Our partnership with AWS has resulted in a Leader recognition by the 2024.

Success stories

Meet our team

Aseem Jain
Amit Hosley

Vice President
MedTech
HCLTech

Jamie Shepard
Jamie Shepard

Global Industry Principal LSH 
Cloud Native Tech Strategy and Advisory
HCLTech

Aseem Jain
Dr. Reena Gollapudy

AVP and Global Head
Biopharma Practice
HCLTech

Jessica Leibson
Jessica Leibson

AWS GTM Lead, Americas
HCLTech

Lindsey Bengfort
Lindsey Bengfort

Strategic Sales Leader
HCLTech

Aseem Jain
Jerwyn Daniel Roy

Account Manager
Life Sciences
HCLTech

Neeraj Kaushlendra
Neeraj Kaushlendra

Practice Director
MedTech
HCLTech

Dr. Antony Prabhu J
Dr. Antony Prabhu J

Head, AI/Gen AI
Product Management
Life Sciences
HCLTech

Our resources